ArticleOncotarget2017

MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression.

Wei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.